CN105601752B - 一种多基因重组嵌合抗原受体分子 - Google Patents
一种多基因重组嵌合抗原受体分子 Download PDFInfo
- Publication number
- CN105601752B CN105601752B CN201610071667.XA CN201610071667A CN105601752B CN 105601752 B CN105601752 B CN 105601752B CN 201610071667 A CN201610071667 A CN 201610071667A CN 105601752 B CN105601752 B CN 105601752B
- Authority
- CN
- China
- Prior art keywords
- polygenes
- antigen receptor
- molecule
- chimeric antigen
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/03—Fusion polypeptide containing a localisation/targetting motif containing a transmembrane segment
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610071667.XA CN105601752B (zh) | 2016-02-01 | 2016-02-01 | 一种多基因重组嵌合抗原受体分子 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610071667.XA CN105601752B (zh) | 2016-02-01 | 2016-02-01 | 一种多基因重组嵌合抗原受体分子 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105601752A CN105601752A (zh) | 2016-05-25 |
CN105601752B true CN105601752B (zh) | 2019-08-23 |
Family
ID=55982154
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610071667.XA Active CN105601752B (zh) | 2016-02-01 | 2016-02-01 | 一种多基因重组嵌合抗原受体分子 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105601752B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106167527A (zh) * | 2016-06-13 | 2016-11-30 | 长沙郝怡雅医药科技有限公司 | 一种融合蛋白 |
CN107522786A (zh) * | 2016-06-20 | 2017-12-29 | 深圳市体内生物医药科技有限公司 | 一种分子、表达其的细胞及其制备方法和用途 |
CA3039992A1 (en) * | 2016-11-02 | 2018-05-11 | Jounce Therapeutics, Inc. | Antibodies to pd-1 and uses thereof |
WO2018103734A1 (zh) * | 2016-12-09 | 2018-06-14 | 北京中捭生物科技有限公司 | 嵌合抗原受体及其用途和制备方法 |
WO2021030166A1 (en) * | 2019-08-09 | 2021-02-18 | Siemens Healthcare Diagnostics Inc. | Anti-hog tcn1 monoclonal antibodies and methods of production and use thereof |
CN110327459B (zh) * | 2019-08-22 | 2022-07-01 | 中国农业科学院上海兽医研究所(中国动物卫生与流行病学中心上海分中心) | 抗病原体感染用靶向免疫检查点pd-l1的融合疫苗 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103965361A (zh) * | 2013-02-06 | 2014-08-06 | 上海细胞治疗工程技术研究中心有限公司 | 一种t细胞信号的嵌合分子转换器及其用途 |
CN103965363A (zh) * | 2013-02-06 | 2014-08-06 | 上海白泽生物科技有限公司 | 与pd-1和vegf高效结合的融合蛋白、其编码序列及用途 |
-
2016
- 2016-02-01 CN CN201610071667.XA patent/CN105601752B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103965361A (zh) * | 2013-02-06 | 2014-08-06 | 上海细胞治疗工程技术研究中心有限公司 | 一种t细胞信号的嵌合分子转换器及其用途 |
CN103965363A (zh) * | 2013-02-06 | 2014-08-06 | 上海白泽生物科技有限公司 | 与pd-1和vegf高效结合的融合蛋白、其编码序列及用途 |
Non-Patent Citations (1)
Title |
---|
《Herstatin,EGFR家族的天然抑制因子》;胡品良;《中国肿瘤生物治疗杂质》;20131231;第10卷(第4期);第304-305页 |
Also Published As
Publication number | Publication date |
---|---|
CN105601752A (zh) | 2016-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105601752B (zh) | 一种多基因重组嵌合抗原受体分子 | |
JP6997267B2 (ja) | 抗ヒトパピローマウイルス16 e7 t細胞受容体 | |
US20240024359A1 (en) | BISPECIFIC OR-GATE CHIMERIC ANTIGEN RECEPTOR RESPONSIVE TO CD19 and CD20 | |
ES2899779T3 (es) | Receptores antigénicos quiméricos dirigidos a receptor acoplado a proteína G y usos de los mismos | |
ES2905557T3 (es) | Receptor de antígeno quimérico anti-CD30 y su uso | |
CN105377886B (zh) | 识别mage-a1的高亲和力结合分子 | |
AU2014225788B2 (en) | Engager cells for immunotherapy | |
US10604740B2 (en) | Nucleic acids encoding chimeric antigen receptor proteins which bind epidermal growth factor receptor and T lymphocyte expressing the protein | |
ES2833162T3 (es) | Receptor de antígeno quimérico y su uso | |
US20210085769A1 (en) | Chimeric antigen receptor specific for tumor cells | |
JP7000315B2 (ja) | 高結合活性hpv t細胞受容体 | |
KR20150030724A (ko) | Car t 세포를 조절하기 위한 조성물 및 방법 | |
JP2020521479A (ja) | キメラ抗原受容体細胞の作製及びその使用 | |
CN107058354A (zh) | 编码嵌合抗原受体蛋白的核酸及表达嵌合抗原受体蛋白的t淋巴细胞 | |
CN109415409A (zh) | Flag标记的cd19-car-t细胞 | |
CN105452288A (zh) | 抗人乳头瘤病毒16 e6 t细胞受体 | |
CN110157738B (zh) | 靶向cd19和cd22的工程化免疫细胞及其应用 | |
CN109593721A (zh) | 具有自杀基因开关的靶向人间皮素的工程化免疫细胞 | |
WO2022199125A1 (zh) | 一种自分泌IL-15与anti-PD1融合蛋白的免疫细胞 | |
ES2690420T3 (es) | Receptor de antígeno quimérico anti-toso y su uso | |
JP7313746B2 (ja) | キメラ抗原受容体及び当該キメラ抗原受容体を発現する免疫エフェクター細胞 | |
US20230357355A1 (en) | Cspg4-targeting humanized chimeric antigen receptor, immune effector cell expressing chimeric antigen receptor, and applications thereof | |
EP4093412A1 (en) | Quantitative control of activity of engineered cells expressing universal immune receptors | |
AU2020346887A1 (en) | Antigen recognizing receptors targeting CD371 and uses thereof | |
WO2023232746A1 (en) | Anti-activated trop-2 chimeric antigen receptor constructs for use in cancer therapy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20190130 Address after: 226100 A2 Floor, No. 100 Dongting Lake Road, Linjiang Town, Haimen City, Nantong City, Jiangsu Province Applicant after: Haimen Haoyeya Pharmaceutical Technology Co., Ltd. Address before: 410000 Jinrui Pioneer Base, 69 Lufeng Road, Changsha High-tech Development Zone, Hunan Province, 239, 2nd floor, Primitive Crystal Source Electronic Testing Center Applicant before: CHANGSHA HAOYIYA MEDICAL TECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200107 Address after: 226100 building A6, No. 100, Dongting Lake Road, Linjiang Town, Haimen City, Nantong City, Jiangsu Province Patentee after: Haimen Ruike Pharmaceutical Technology Co., Ltd Address before: 226100 A2 Floor, No. 100 Dongting Lake Road, Linjiang Town, Haimen City, Nantong City, Jiangsu Province Patentee before: Haimen Haoyeya Pharmaceutical Technology Co., Ltd. |
|
TR01 | Transfer of patent right | ||
CP03 | Change of name, title or address |
Address after: 226100 A6 / F, No.100 Dongtinghu Road, Linjiang Town, Haimen District, Nantong City, Jiangsu Province Patentee after: Nantong Kerui Technology Co.,Ltd. Address before: 226100 building A6, No. 100, Dongting Lake Road, Linjiang Town, Haimen City, Nantong City, Jiangsu Province Patentee before: Haimen Ruike Pharmaceutical Technology Co.,Ltd. |
|
CP03 | Change of name, title or address |